UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~December~~March, ~~2024~~ 2025

Commission File Number: ~~333~~ 001-~~275953~~41999

Linkers Industries Limited (Registrant’s Name)

(Registrant’s Name)

Lot A99, Jalan 2A-3, A101 & A102, Jalan 2A, Kawasan Perusahaan MIEL

Sungai Lalang, 08000 Sungai Petani, Kedah Darul Aman, Malaysia

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

OnNasdaq ~~December~~Minimum ~~16,~~Bid ~~2024,~~Price R.Deficiency F, Lafferty & Co., Inc., the underwriter of the initial public offering (the “IPO”) of Linkers Industries Limited, a British Virgin Islands Company (the “Company”), notified the Company of their decision to exercise the over-allotment option to purchase an additional 285,000 class A ordinary shares (the “Over-allotment Shares”) of the Company, par value $0.00001 per share, at a price of $4.00 per share. The closing for the sale of the Over-allotment Shares took place on December 19, 2024.Letter

~~Gross~~On March ~~proceeds~~10, of2025, Linkers Industries Limited. (the “Company’s”) ~~IPO,~~received ~~including~~a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the ~~proceeds~~Company ~~from~~that based on the ~~sale~~closing bid price of the ~~Over-allotment~~Company ~~Shares~~for the period from January 24, ~~totaled~~2025 ~~approximately~~to ~~$1.14~~March ~~million~~7, ~~before~~2025, ~~deducting~~the ~~underwriting~~Company ~~discounts~~no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules ~~and~~5550(a)(2), ~~other~~to ~~related~~maintain ~~expenses~~a minimum bid price of $1 per share.

~~This~~Nasdaq has ~~report~~provided the Company with an 180 calendar days compliance period, or until September 8, 2025, in which to regain compliance with Nasdaq continued listing requirement. In the event that the Company does not ~~constitute~~regain compliance in the compliance period, the Company may be eligible for an ~~offer~~additional to180 ~~sell~~calendar days, should the Company meet the continued listing requirement for market value of publicly orheld shares and all other initial listing standards for The Nasdaq Capital Market, with the ~~solicitation~~exception of anthe ~~offer~~bid toprice ~~buy~~requirement, ~~nor~~and is ~~shall~~able ~~there~~to beprovide ~~any~~written ~~sale~~notice of ~~these~~its ~~securities~~intention into ~~any~~cure ~~state~~the ordeficiency ~~jurisdiction~~during inthe ~~which~~second ~~such~~compliance ~~offer~~period, by effecting a reverse ~~solicitation~~stock split, orif ~~sale~~necessary. ~~would~~However, beif ~~unlawful~~it ~~prior~~appears that the Company will not be able to cure the ~~registration~~deficiency, or ~~qualification~~if ~~under~~ the ~~securities~~Company ~~laws~~is ofotherwise not ~~any~~eligible, ~~such~~Nasdaq ~~state~~will orprovide ~~jurisdiction~~notice that the Company’s securities will be subject to delisting.

The Company is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaq’s continued listing requirement. Although the Company will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other Nasdaq continued listing requirement.

On March 13, 2025, the Company issued a press release discussing the receipt of the deficiency letter, which is filed as exhibit 99.1 to this Form 6-K.

Financial Statements and Exhibits.

The following exhibits are being filed herewith:

Exhibit No.		Description
99.1		Press Release

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Linkers Industries Limited
Date: December 23, 2024	By:	/s/ Man Tak Lau
Date: March 13, 2025	By:	/s/ Man Tak Lau
	Name:	Man Tak Lau
	Title:	Chairman of the Board of Directors

Filing Compare · Linkers Industries Ltd